1. Home
  2. YMAB vs TWI Comparison

YMAB vs TWI Comparison

Compare YMAB & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • TWI
  • Stock Information
  • Founded
  • YMAB 2015
  • TWI 1890
  • Country
  • YMAB United States
  • TWI United States
  • Employees
  • YMAB N/A
  • TWI N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • TWI Steel/Iron Ore
  • Sector
  • YMAB Health Care
  • TWI Industrials
  • Exchange
  • YMAB Nasdaq
  • TWI Nasdaq
  • Market Cap
  • YMAB 482.4M
  • TWI 480.2M
  • IPO Year
  • YMAB 2018
  • TWI 1993
  • Fundamental
  • Price
  • YMAB $9.38
  • TWI $7.91
  • Analyst Decision
  • YMAB Strong Buy
  • TWI Strong Buy
  • Analyst Count
  • YMAB 10
  • TWI 1
  • Target Price
  • YMAB $21.00
  • TWI $11.00
  • AVG Volume (30 Days)
  • YMAB 243.1K
  • TWI 884.7K
  • Earning Date
  • YMAB 11-08-2024
  • TWI 10-30-2024
  • Dividend Yield
  • YMAB N/A
  • TWI N/A
  • EPS Growth
  • YMAB N/A
  • TWI N/A
  • EPS
  • YMAB N/A
  • TWI N/A
  • Revenue
  • YMAB $84,553,000.00
  • TWI $1,852,563,000.00
  • Revenue This Year
  • YMAB $6.46
  • TWI $3.14
  • Revenue Next Year
  • YMAB $20.68
  • TWI N/A
  • P/E Ratio
  • YMAB N/A
  • TWI N/A
  • Revenue Growth
  • YMAB N/A
  • TWI N/A
  • 52 Week Low
  • YMAB $6.09
  • TWI $6.34
  • 52 Week High
  • YMAB $20.90
  • TWI $15.33
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 32.17
  • TWI 54.36
  • Support Level
  • YMAB $9.31
  • TWI $7.44
  • Resistance Level
  • YMAB $11.10
  • TWI $8.18
  • Average True Range (ATR)
  • YMAB 0.72
  • TWI 0.57
  • MACD
  • YMAB -0.00
  • TWI 0.04
  • Stochastic Oscillator
  • YMAB 3.87
  • TWI 41.60

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: